Practice
Featured experience
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
EquipmentShare $860 million IPO
We advised EquipmentShare on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Biocytogen RMB1.27 billion Shanghai IPO
We advised Biocytogen on its IPO and SSE listing
ChargePoint Holdings $150 million at-the-market offering
We advised the sales agent on the offering
Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering
CoreWeave $2.6 billion convertible senior notes offering
We advised CoreWeave on the offering
Seyond Holdings HK$11.7 billion de-SPAC transaction and private placement
We advised Seyond on the transactions
HNI senior secured notes exchange offer
We advised HNI on the exchange offer
Strive $500 million at-the-market preferred offering
We advised Strive on the offering
Deutsche Bank $1 billion notes offering
We advised the sole bookrunner, joint lead managers and co-managers on the offering
Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering